Effect of a novel cognitive enhancer on decreased CaMKII activity in Schizophrenia model rats

被引：0
|
作者：
Yabuki, Y. [1 ]
Fukunaga, K. [1 ]
机构：
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan
来源：
JOURNAL OF NEUROCHEMISTRY | 2015年 / 134卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
WTH11-19
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [41] Increased CaMKII-dependent pro-arrhythmic activity in a novel mouse model of obstructive sleep apnoea
    Schaner, B.
    Lebek, S.
    Hegner, P.
    Maier, L. S.
    Arzt, M.
    Wagner, S.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3316 - 3316
  • [42] Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats
    Matson, David J.
    Broom, Daniel C.
    Carson, Susan R.
    Baldassari, James
    Kehne, John
    Cortright, Daniel N.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01): : 194 - 201
  • [43] The Mouse Socially-evoked Activity Task as a novel animal model of schizophrenia
    Mihara, Takuma
    Siegel, Steven. J.
    Sobota, Rosanna. M.
    Lin, Robert
    Featherstone, Robert. E.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 70P - 70P
  • [44] A novel Kv3 ion channel modulator restores cognitive function in an animal model of cognitive impairment in schizophrenia
    Neill, J.
    Grayson, B.
    Marsh, S.
    Harte, M. K.
    Large, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S490 - S490
  • [45] A novel KV3 ion channel modulator restores cognitive function in an animal model of cognitive impairment in schizophrenia
    Leger, M.
    Grayson, B.
    Marsh, S.
    Harte, M.
    Neill, J.
    Large, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S49 - S50
  • [46] The Attentional Set-Shifting Test Paradigm in Rats for the Screening of Novel Pro-Cognitive Compounds with Relevance for Cognitive Deficits in Schizophrenia
    Goetghebeur, Pascal Jean Denis
    Dias, Rebecca
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (31) : 5060 - 5068
  • [47] The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia
    Sanna K. Janhunen
    Heta Svärd
    John Talpos
    Gaurav Kumar
    Thomas Steckler
    Niels Plath
    Linda Lerdrup
    Trine Ruby
    Marie Haman
    Roger Wyler
    Theresa M. Ballard
    Psychopharmacology, 2015, 232 : 4059 - 4083
  • [48] Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology
    Neill, Jo C.
    Grayson, Ben
    Kiss, Bela
    Gyertyan, Istvan
    Ferguson, Paul
    Adham, Nika
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (01) : 3 - 14
  • [49] EFFECT OF CLOZAPINE ON NEUROCOGNITIVE AND SOCIAL COGNITIVE FUNCTIONS IN A SCHIZOPHRENIA-LIKE MOUSE MODEL
    Kawai, Shunya
    Yoshimi, Akira
    Kato, Ayaka
    Uchida, Mizuki
    Kitagaki, Shinji
    Ozaki, Norio
    Noda, Yukihiro
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i174 - i175
  • [50] The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia
    Janhunen, Sanna K.
    Svard, Heta
    Talpos, John
    Kumar, Gaurav
    Steckler, Thomas
    Plath, Niels
    Lerdrup, Linda
    Ruby, Trine
    Haman, Marie
    Wyler, Roger
    Ballard, Theresa M.
    PSYCHOPHARMACOLOGY, 2015, 232 (21-22) : 4059 - 4083
12345